Xvivo Perfusion AB | Balance Sheet
Fiscal year is January-December. All values SEK Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
4,131.00
48,203.00
41,234.00
24,871.00
195,322.00
187,064
Total Accounts Receivable
8,698.00
13,552.00
20,984.00
32,100.00
30,772.00
46,925
Inventories
17,990.00
26,190.00
28,598.00
34,551.00
30,703.00
36,387
Other Current Assets
2,202.00
5,197.00
4,819.00
7,343.00
7,825.00
7,304
Total Current Assets
33,021.00
93,142.00
95,635.00
98,865.00
264,622.00
277,680
Net Property, Plant & Equipment
917.00
1,124.00
7,123.00
15,166.00
16,277.00
15,615
Total Investments and Advances
2,784.00
-
-
-
71.00
71
Intangible Assets
89,222.00
99,341.00
96,935.00
223,807.00
242,175.00
279,698
Other Assets
-
3,176.00
-
-
-
-
Total Assets
127,565.00
201,701.00
204,180.00
350,119.00
538,540.00
586,612
ST Debt & Current Portion LT Debt
6,659.00
-
-
-
-
Accounts Payable
8,419.00
6,468.00
3,650.00
12,563.00
11,121.00
Income Tax Payable
3,212.00
3,531.00
2,009.00
-
45.00
Other Current Liabilities
7,368.00
8,759.00
9,922.00
18,036.00
19,730.00
Total Current Liabilities
25,658.00
18,758.00
15,581.00
30,599.00
30,896.00
Provision for Risks & Charges
3,459.00
4,068.00
1,033.00
1,237.00
1,351.00
Deferred Taxes
192.00
2,226.00
1,795.00
10,474.00
13,434.00
Total Liabilities
30,930.00
25,518.00
19,306.00
33,643.00
34,208.00
Common Equity (Total)
96,635.00
176,183.00
184,874.00
316,476.00
504,332.00
Total Shareholders' Equity
96,635.00
176,183.00
184,874.00
316,476.00
504,332.00
Total Equity
96,635.00
176,183.00
184,874.00
316,476.00
504,332.00
Liabilities & Shareholders' Equity
127,565.00
201,701.00
204,180.00
350,119.00
538,540.00
About Xvivo Perfusion AB
View Profile
